Bongomin F, Gago S, Oladele RO, Denning DW (2017) Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi 3(4):57. https://doi.org/10.3390/jof3040057
Vazquez JA, Sobel JD (2011) Candidiasis. Essentials of clinical mycology. Springer, New York, pp 167–206. https://doi.org/10.1007/978-1-4419-6640-7_11
Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Edwards JE, Dismukes WE, NIAID Mycoses Study Group (2003) A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis Offic Publ Infect Dis Soc Am 37(5):634–643. https://doi.org/10.1086/376906
Fidel PL Jr, Sobel JD (1996) Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 9(3):335–348. https://doi.org/10.1128/CMR.9.3.335
Article PubMed PubMed Central Google Scholar
Singh A, Verma R, Murari A, Agrawal A (2014) Oral candidiasis: an overview. J Oral Maxillofac Pathol 18(Suppl 1):S81–S85. https://doi.org/10.4103/0973-029X.141325
Article PubMed PubMed Central Google Scholar
Gow NA, van de Veerdonk FL, Brown AJ, Netea MG (2011) Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 10(2):112–122. https://doi.org/10.1038/nrmicro2711
Article CAS PubMed PubMed Central Google Scholar
Woolfson AD, Malcolm RK, Gallagher R (2000) Drug delivery by the intravaginal route. Crit Rev Ther Drug Carrier Syst 17(5):509–555
Article CAS PubMed Google Scholar
Nett JE, Andes DR (2020) Contributions of the biofilm matrix to Candida pathogenesis. J Fungi 6(1):21. https://doi.org/10.3390/jof6010021
LaFleur MD, Kumamoto CA, Lewis K (2006) Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 50(11):3839–3846. https://doi.org/10.1128/AAC.00684-06
Article CAS PubMed PubMed Central Google Scholar
Barnett SE, Carrillo NAnn (2014) Candidiasis. Equine infectious diseases. WB Saunders, pp 408–411
Dowd FJ (2014) Candida albicans infections
Samaranayake LP, Ellepola AN (2000) Studying Candida albicans adhesion. Handbook of bacterial adhesion. Humana Press, Totowa, pp 527–540. https://doi.org/10.1007/978-1-59259-224-1_33
Delaloye J, Calandra T (2014) Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 5(1):161–169. https://doi.org/10.4161/viru.26187
Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ (2018) Invasive candidiasis. Nat Rev Dis Primers 4:18026. https://doi.org/10.1038/nrdp.2018.26
Yike I (2011) Fungal proteases and their pathophysiological effects. Mycopathologia 171(5):299–323. https://doi.org/10.1007/s11046-010-9386-2
Article CAS PubMed Google Scholar
Calderone RA, Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9(7):327–335. https://doi.org/10.1016/s0966-842x(01)02094-7
Article CAS PubMed Google Scholar
Schaller M, Korting HC, Schäfer W, Bastert J, Chen W, Hube B (1999) Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol 34(1):169–180. https://doi.org/10.1046/j.1365-2958.1999.01590.x
Article CAS PubMed Google Scholar
Hube B, Sanglard D, Odds FC, Hess D, Monod M, Schäfer W, Brown AJ, Gow NA (1997) Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun 65(9):3529–3538. https://doi.org/10.1128/iai.65.9.3529-3538.1997
Article CAS PubMed PubMed Central Google Scholar
Naglik JR, Challacombe SJ, Hube B (2003) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67(3):400–428. https://doi.org/10.1128/MMBR.67.3.400-428.2003
Article CAS PubMed PubMed Central Google Scholar
Naglik J, Albrecht A, Bader O, Hube B (2004) Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 6(10):915–926. https://doi.org/10.1111/j.1462-5822.2004.00439.x
Article CAS PubMed Google Scholar
Gropp K, Schild L, Schindler S, Hube B, Zipfel PF, Skerka C (2009) The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol 47(2–3):465–475. https://doi.org/10.1016/j.molimm.2009.08.019
Article CAS PubMed Google Scholar
Calderone RA, Clancy CJ (Eds.). (2011). Candida and candidiasis. American Society for Microbiology Press
Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE, Infectious Diseases Society of America (2004) Guidelines for treatment of candidiasis. Clin Infect Dis Offic Publ Infect Dis Soc Am 38(2):161–189. https://doi.org/10.1086/380796
Spellberg B, Witt MD, Beck CK (2004) Amphotericin B: is a lipid-formulation gold standard feasible? Clin Infect Dis Offic Publ Infect Dis Soc Am 38(2):304–307. https://doi.org/10.1086/380844
Spellberg BJ, Filler SG, Edwards JE Jr (2006) Current treatment strategies for disseminated candidiasis. Clin Infect Dis Offic Publ Infect Dis Soc Am 42(2):244–251. https://doi.org/10.1086/499057
Bouzada ML, Fabri RL, Nogueira M, Konno TU, Duarte GG, Scio E (2009) Antibacterial, cytotoxic and phytochemical screening of some traditional medicinal plants in Brazil. Pharm Biol 47(1):44–52. https://doi.org/10.1080/13880200802411771
Arif T, Bhosale JD, Kumar N, Mandal TK, Bendre RS, Lavekar GS, Dabur R (2009) Natural products–antifungal agents derived from plants. J Asian Nat Prod Res 11(7):621–638. https://doi.org/10.1080/10286020902942350
Article CAS PubMed Google Scholar
Duraipandiyan V, Ignacimuthu S (2011) Antifungal activity of traditional medicinal plants from Tamil Nadu, India. Asian Pac J Trop Biomed 1(2):S204–S215. https://doi.org/10.1016/S2221-1691(11)60157-3
Fathallah N, Raafat MM, Issa MY, Abdel-Aziz MM, Bishr M, Abdelkawy MA, Salama O (2019) Bio-guided fractionation of prenylated benzaldehyde derivatives as potent antimicrobial and antibiofilm from Ammi majus L. fruits-associated Aspergillus amstelodami. Molecules 24(22):4118
Article CAS PubMed PubMed Central Google Scholar
Rao PR, Nammi S, Raju ADV (2002) Studies on the antimicrobial activity of Heliotropium indicum Linn. J Nat Rem 2(2):195–198
Roy A (2015) Pharmacological activities of Indian Heliotrope (Heliotropium indicum L.): a review. J Pharm Phytochem 4(3):101
Jayaram U, Srivastava N (2016) Ethnopharmacological and phytochemical profile of three potent Desmodium species: Desmodium gangeticum (L.) DC, Desmodium triflorum Linn. and Desmodium triquetrum Linn. J Chem Pharm Res 8(7):91–97
Rose PW, Prlić A, Altunkaya A, Bi C, Bradley AR, Christie CH, Costanzo LD, Duarte JM, Dutta S, Feng Z, Green RK, Goodsell DS, Hudson B, Kalro T, Lowe R, Peisach E, Randle C, Rose AS, Shao C, Tao YP, Burley SK (2017) The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Res 45(D1):D271–D281. https://doi.org/10.1093/nar/gkw1000
Article CAS PubMed Google Scholar
Sankararaman S, Sha F, Kirsch JF, Jordan MI, Sjölander K (2010) Active site prediction using evolutionary and structural information. Bioinformatics 26(5):617–624. https://doi.org/10.1093/bioinformatics/btq008
Article CAS PubMed PubMed Central Google Scholar
Sasikumar AP, Ramaswamy S, Sudhir S (2022) A scientific pharmacognosy on Gaucher’s disease: an in silico analysis. Environ Sci Pollut Res Int 29(17):25308–25317. https://doi.org/10.1007/s11356-021-17534-y
Sinha S, Patel S, Athar M, Vora J, Chhabria MT, Jha PC, Shrivastava N (2019) Structure-based identification of novel sirtuin inhibitors against triple negative breast cancer: an in silico and in vitro study. Int J Biol Macromol 140:454–468. https://doi.org/10.1016/j.ijbiomac.2019.08.061
Article CAS PubMed Google Scholar
Vijayakumar S, Manogar P, Prabhu S, Sanjeevkumar Singh RA (2018) Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer’s disease. J Pharm Anal 8(6):413–420. https://doi.org/10.1016/j.jpha.2017.07.006
Nurhan AD, Gani MA, Maulana S, Siswodihardjo S, Ardianto C, Khotib J (2022) Molecular docking studies for protein-targeted drug development in SARS-CoV-2. Lett Drug Des Discov 19(5):428–439. https://doi.org/10.2174/1570180818666210512021619
Qikprop, module 4.4 (2012) Schrodinger suite, New York
Yusof I, Segall MD (2013) Considering the impact drug-like properties have on the chance of success. Drug Discov Today 18(13–14):659–666. https://doi.org/10.1016/j.drudis.2013.02.008
Article CAS PubMed Google Scholar
Filimonov DA, Lagunin AA, Gloriozova TA, Rudik AV, Druzhilovskii DS, Pogodin PV, Poroikov VV (2014) Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem Heterocycl Compd 50(3):444–457. https://doi.org/10.1007/s10593-014-1496-1
留言 (0)